欧洲ivd 管理事务外包市场需求、机会和预测

欧洲 IVD 监管事务外包市场，按服务（监管撰写及提交、监管注册及临床试验申请、监管咨询、法律代表、数据管理服务、化学制造及控制 (CMC) 服务及其他）、适应症（肿瘤学、神经病学、心脏病学、临床化学和免疫测定、精准医疗、传染病、糖尿病、基因检测、艾滋病毒/艾滋病、血液学、药物检测/药物基因组学、输血、护理点及其他）、部署模式（云和本地）、组织规模（中小型企业 (SMES) 和大型企业）、阶段（临床、临床前和 PMA（上市后授权））、类别（I 类、II 类和 III 类）、最终用户（制药公司、医疗器械公司、生物技术公司及其他）、国家（德国、法国、英国、意大利、西班牙、荷兰、瑞士、俄罗斯、土耳其、比利时及其他地区）划分欧洲）行业趋势及预测至2029年。

市场分析和见解欧洲IVD管理事务外包市场

欧洲IVD监管事务外包市场预计将在2022至2029年的预测期内获得市场增长. 数据桥市场研究分析认为,在2022至2029年的预测期内,市场增长12.8%,预计到2029年将达到527,875.85万美元。

体外活动诊断产品是用于诊断疾病或其他情况的试剂、装置和系统,包括确定一个人的健康状况以治疗、减轻、治疗或预防疾病。这些产品旨在用于人体标本的收集、准备和检查。监管事务在体外诊断器械(IVD)和医疗器械行业中发挥着至关重要的作用. 监管事务外包服务涉及为临床研究项目提供高质量文件的专业人员撰写和出版监管文件。在新兴经济体进行的临床研究中,对监管服务外包的需求正在大幅增加,为这一行业的增长提供了一个健康的平台。

推动IVD监管事务外包市场增长的主要因素是:全区慢性病发病率上升;各种体外诊断器械的技术进步. 组织间战略收购和伙伴关系的兴起为市场的增长创造了机会。不同区域医疗器械条例的改变是IVD管理事务外包市场的主要制约因素。保健服务缺乏基础设施是市场增长的一大挑战。

本IVD监管事务外包市场报告详细介绍了市场份额,新发展,以及产品管线分析,国内和地方化市场主体的影响,分析新兴收益口袋,市场监管变化,产品审批,战略决策,产品推出,地域扩张,市场技术创新等方面的机会. 为了了解分析和市场情况与我们联系一份分析简报, 我们的团队将帮助你建立一个收入影响解决方案实现你的理想目标。

欧洲IVD 管理事务外包市场范围和市场规模

欧洲IVD管理事务外包市场分为七个值得注意的部分,这些部分基于服务、指示、部署模式、组织规模、舞台、类和终端用户。

在服务的基础上,欧洲IVD监管事务外包市场被分为监管书写和提交,监管注册和临床试验应用,监管咨询,法律代理,数据管理服务,化学制造和控制(CMC)服务等. 2022年,由于监管书写和提交涉及产品的法律代理,以及由于严格的条例可能将国家改为国家,由于资源需求高和政策变化,涉及高资源消耗,因此预计将主导市场。
根据说明,欧洲IVD监管事务外包市场分为肿瘤学,神经学,心脏病学,临床化学和免疫学,精密医学,传染病,糖尿病,遗传检测,艾滋病毒/艾滋病,出血学,药物检测/药物基因组学,输血,护理点等. 2022年,肿瘤分会有望占据主导地位,因为它有助于提高肿瘤药物开发过程的可预测性,并成为肿瘤学家在患者选择治疗方面的重要工具.
根据部署模式,欧洲IVD管理事务外包市场被分割成云和地壳. 2022年,云段预计会占据主导地位,因为它具有成本效益,而云计算技术在IVD监管中的解决方案灵活特性为IVD交易组织提供了稳定的基础设施,最大输出.
根据组织规模,欧洲IVD监管事务外包市场被划分为中小企业和大型企业. 2022年,随着与IVD监管应用相关的高品质技术和服务组合吸引同行更多参与,大型企业分部预计将占据主导地位.
在阶段的基础上,欧洲IVD监管事务外包市场被分割成临床,临床前和PMA(市场后授权). 2022年,临床部分预计会主导市场,因为对人类主体进行的临床试验提供了对设备实际情景的洞察. 临床试验分多个阶段进行,是一个漫长的程序,涉及多种安全程序和遵守监管机构的规定。这使得其价格昂贵,并且有很高的初始投资. 由于这是一个强制过程,而且涉及高昂的费用,因此这个部分占主导地位。
根据等级,欧洲IVD监管事务外包市场分为一级,二级,三级. 2022年,一级部门预计将主导市场,因为它不涉及公共卫生风险或低个人风险,监管最低。这些医疗器械的需求很大,47%的医疗器械属于这一类别。
在最终用户的基础上,欧洲IVD监管事务外包市场被分割成制药公司,医疗器械公司,生物技术公司等. 2022年,医疗器械公司预计会主导市场,因为这些公司有很长的装置开发时间,这受到正在变化的条例的影响,这种遵守可能耗费时间并浪费资源.

欧洲IVD 监管事务外包市场

分析欧洲IVD监管事务外包市场,由国家,服务,指示,部署模式,组织规模,舞台,类和终端用户提供市场规模信息.

欧洲IVD监管事务外包市场报告涵盖的国家有:德国、法国、英国、意大利、西班牙、荷兰、瑞士、俄罗斯、土耳其、比利时和欧洲其他一些国家。

由于卫生保健部门的发展和各种体外诊断设备的技术进步,德国正在主导市场。

报告的国家部分还介绍了影响市场的因素和国内市场监管的变化,这些因素和变化影响到市场目前和未来的趋势。新的销售、替代销售、国家人口统计、管制条例和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。此外,考虑到全球品牌的存在和可得性及其由于来自当地和国内品牌的大规模或稀缺竞争而面临的挑战,在对国家数据进行预测分析的同时,还考虑了销售渠道的影响。

IVD管理事务外包需求增加

欧洲IVD监管事务外包市场还为各国工业增长提供了详细的市场分析,包括销售量,部件销售量,IVD监管事务外包的技术发展影响以及监管情景的变化,支持IVD监管事务外包市场. 现有2012年至2020年历史时期的数据。

竞争性景观和欧洲IVD管理事务外包市场份额分析

欧洲IVD监管事务外包市场竞争景观提供竞争对手的详细信息. 详细情况包括:公司概况,公司财务,创收,市场潜力,研发投资,新市场举措,全球存在,生产地和设施,公司优势和弱点,产品推出,产品试验管线,产品审批,专利,产品宽度和广度,应用优势,技术命脉曲线等. 上述数据点仅涉及与欧洲IVD监管事务外包市场有关的公司重点。

报告内的一些主要角色是IVD监管事务外包市场:Freyr Solutions,PPD Inc.(Thremofisher Science Inc.的子公司),EMERGO,ICON,Parexel International Corporation,CRITERIUM,INC.,Groupe ProductLife S.A.,Labcorp Drugy Development,Wuxi AppTec,Genpact,Medpac,Dor Dharmet Services,Qserve等. DBMR分析师了解竞争优势,为每个竞争者分别提供竞争分析.

世界各地的公司也发起了许多产品开发,也正在加速欧洲IVD管理事务外包市场的增长。

比如说,

2019年10月,多尔制药服务公司宣布已启动包装材料生产新服务并发布医疗产品广告. 这些服务涵盖各个方面,从翻译包装材料到使其适应卫生部的要求,从图形制作到印刷包装材料。因此,通过这一新的服务启动,公司将能够针对新的客户群体,客户可以进行更精确的选择。
2021年10月,Proparma集团收购了Pharmica Consult. ProPharma Group是奥德赛投资伙伴公司(Odyssey Investment Partners)的一家投资组合公司,已经收购了Pharmica Consultation,一家生命科学咨询公司,为制药和生物技术公司提供项目管理(PM)咨询解决方案和专有业务软件,以进行临床试验. 这帮助了公司在全球市场扩展业务.

伙伴关系、合资企业和其他战略提高了公司的市场份额,增加了覆盖面和存在。它还为组织通过扩大规模改进对IVD管理事务外包的报价提供了好处。

SKU-67920

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 2 EUROPE REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 3 EUROPE LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 4 EUROPE REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 5 EUROPE REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 6 EUROPE CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 7 EUROPE DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND)

TABLE 8 EUROPE OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 9 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 10 EUROPE CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 11 EUROPE INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND)

TABLE 12 EUROPE INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 13 EUROPE HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 14 EUROPE DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 15 EUROPE PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 16 EUROPE DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 17 EUROPE BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 18 EUROPE CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 19 EUROPE POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 20 EUROPE POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 21 EUROPE ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 22 EUROPE NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 23 EUROPE HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 24 EUROPE GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 25 EUROPE OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 26 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 27 EUROPE CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 28 EUROPE CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 29 EUROPE CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 30 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 31 EUROPE CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 32 EUROPE ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 33 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 34 EUROPE LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 35 EUROPE SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 36 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 37 EUROPE CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 38 EUROPE PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 39 EUROPE PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 40 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 41 EUROPE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 42 EUROPE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 43 EUROPE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 44 EUROPE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 45 EUROPE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 46 EUROPE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 47 EUROPE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 48 EUROPE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 49 EUROPE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 50 EUROPE OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 51 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 52 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 53 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 54 EUROPE INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 55 EUROPE POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 56 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 57 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 58 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 59 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 60 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 61 EUROPE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 62 EUROPE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 63 EUROPE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 64 EUROPE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 65 EUROPE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 66 EUROPE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 67 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 68 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 69 GERMANY INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 70 GERMANY POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 71 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 72 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 73 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 74 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 75 GERMANY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 76 GERMANY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 77 GERMANY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 78 GERMANY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 79 GERMANY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 80 GERMANY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 81 GERMANY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 82 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 83 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 84 FRANCE INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 85 FRANCE POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 86 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 87 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 88 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 89 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 90 FRANCE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 91 FRANCE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 92 FRANCE MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 93 FRANCE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 94 FRANCE PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 95 FRANCE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 96 FRANCE BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 97 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 98 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 99 ITALY INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 100 ITALY POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 101 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 102 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 103 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 104 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 105 ITALY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 106 ITALY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 107 ITALY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 108 ITALY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 109 ITALY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 110 ITALY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 111 ITALY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 112 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 113 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 114 SPAIN INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 115 SPAIN POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 116 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 117 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 118 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 119 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 120 SPAIN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 121 SPAIN MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 122 SPAIN MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 123 SPAIN PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 124 SPAIN PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 125 SPAIN BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 126 SPAIN BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 127 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 128 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 129 U.K. INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 130 U.K. POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 131 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 132 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 133 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 134 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 135 U.K. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 136 U.K. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 137 U.K. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 138 U.K. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 139 U.K. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 140 U.K. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 141 U.K. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 142 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 143 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 144 RUSSIA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 145 RUSSIA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 146 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 147 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 148 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 149 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 150 RUSSIA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 151 RUSSIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 152 RUSSIA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 153 RUSSIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 154 RUSSIA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 155 RUSSIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 156 RUSSIA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 157 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 158 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 159 TURKEY INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 160 TURKEY POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 161 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 162 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 163 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 164 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 165 TURKEY IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 166 TURKEY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 167 TURKEY MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 168 TURKEY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 169 TURKEY PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 170 TURKEY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 171 TURKEY BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 172 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 173 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 174 SWITZERLAND INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 175 SWITZERLAND POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 176 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 177 SWITZERLAND. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 178 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 179 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 180 SWITZERLAND IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 181 SWITZERLAND MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 182 SWITZERLAND MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 183 SWITZERLAND PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 184 SWITZERLAND PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 185 SWITZERLAND BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 186 SWITZERLAND BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 187 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 188 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 189 BELGIUM INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 190 BELGIUM POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 191 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 192 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 193 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 194 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 195 BELGIUM IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 196 BELGIUM MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 197 BELGIUM MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 198 BELGIUM PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 199 BELGIUM PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 200 BELGIUM BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 201 BELGIUM BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 202 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 203 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 204 NETHERLANDS INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 205 NETHERLANDS POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 206 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 207 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 208 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 209 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 210 NETHERLANDS IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 211 NETHERLANDS MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 212 NETHERLANDS MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 213 NETHERLANDS PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 214 NETHERLANDS PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 215 NETHERLANDS BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 216 NETHERLANDS BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 217 REST OF EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

图片列表

FIGURE 1 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 2 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS

FIGURE 4 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID

FIGURE 10 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029

FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET

FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017)

FIGURE 16 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021

FIGURE 17 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021

FIGURE 18 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021

FIGURE 19 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021

FIGURE 20 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021

FIGURE 21 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021

FIGURE 22 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021

FIGURE 23 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021)

FIGURE 24 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021)

FIGURE 25 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029)

FIGURE 26 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029)

FIGURE 27 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029)

FIGURE 28 EUROPE IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

常见问题

预测2022至2029年的预测期间,市场将以何种增长率增长?

预计欧洲IVD事务监管外包市场在2022年至2029年的预测期间将增长12.8%。

未来的市场价值是什么?

在2022至2029年的预测期间,欧洲IVD管理事务外包市场预计将有527,875.85万美元。

市场增长繁荣的重要因素是什么?

推动IVD监管事务外包市场增长的主要因素是:全区慢性病发病率上升;各种体外诊断器械的技术进步.

谁是在市场上经营的主要角色?

报告的主要参与者是IVD监管事务外包市场:Freyr Solutions,PPD Inc.(Thremofisher Science Inc.),EMERGO,ICON,Parexel International Corporation,CRITERIUM,INC. Groupe ProductLife S.A.,Labcorp Drug Drew Development,Wuxi AppTec,Genpact,Medpac,Dor Drophical Services,Qserve等.